Sam Altman invested $10,000 in a brain preservation procedure that is 100% fatal. Is this a sign of an AGI future, or are we just seeing some interesting sci-fi?

A resurfaced 2018 investment by OpenAI CEO Sam Altman reveals a provocative personal interest in the frontier of human-AI integration. Altman paid $10,000 to join the waiting list for Nectome, a startup proposing a brain preservation technique aimed at future "mind uploading." The controversial catch: the process is 100% fatal, requiring euthanasia to chemically fix the brain's intricate neural connections (the connectome) immediately upon death to prevent degradation. This investment, separate from his role at OpenAI, offers a window into Altman's long-term thinking about consciousness and identity in an AGI future.

Parallel to this, Altman has backed Worldcoin's global iris-scanning initiative, framed as a biometric identity system for a post-AGI world. Analysts connect these dots—high-resolution neural mapping, universal biometric IDs, and AGI development—as pieces of a speculative puzzle. The vision suggests a future where human consciousness could potentially be interfaced with or transferred to machine substrates, moving beyond physical keyboards to direct neural links. While currently in the realm of speculative science, these investments fuel discussions about the ethical boundaries of tech leadership and the ultimate endgame for human-computer symbiosis as AGI development accelerates.